Literature DB >> 10372683

Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women.

E Carmina1, R A Lobo.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10372683     DOI： 10.1210/jcem.84.6.5803

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  92 in total

Review 1.  Antenatal treatment of a mother bearing a fetus with congenital adrenal hyperplasia.

Authors:  C G Brook
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-05       Impact factor: 5.747

2.  Distribution of adiponectin multimeric forms in Chinese women with polycystic ovary syndrome and their relation to insulin resistance.

Authors:  Tao Tao; Edmond P Wickham; Wuqiang Fan; Jiejin Yang; Wei Liu
Journal:  Eur J Endocrinol       Date:  2010-06-07       Impact factor: 6.664

3.  The use and misuse of matching in case-control studies: the example of polycystic ovary syndrome.

Authors:  Michael S Bloom; Enrique F Schisterman; Mary L Hediger
Journal:  Fertil Steril       Date:  2007-04-11       Impact factor: 7.329

4.  Serum adiponectin in women with polycystic ovarian syndrome and its relation to clinical, metabolic and endocrine parameters.

Authors:  L Sieminska; B Marek; B Kos-Kudla; D Niedziolka; D Kajdaniuk; M Nowak; J Glogowska-Szelag
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 5.  The impact of obesity on egg quality.

Authors:  Scott H Purcell; Kelle H Moley
Journal:  J Assist Reprod Genet       Date:  2011-05-28       Impact factor: 3.412

6.  The association of Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene with the metabolic characteristics in Chinese women with polycystic ovary syndrome.

Authors:  Jiejin Yang; Hao Gong; Wei Liu; Tao Tao
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

7.  Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome.

Authors:  Jin Yeong Kim; Haengseok Song; Hyunjoo Kim; Hee Jung Kang; Jin Hyun Jun; Sung Ran Hong; Mi Kyoung Koong; In Sun Kim
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

Review 8.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

9.  Predictive value of ovarian stroma measurement for cardiovascular risk in polycyctic ovary syndrome: a case control study.

Authors:  Giuseppe Loverro; Giovanni De Pergola; Edoardo Di Naro; Massimo Tartagni; Cristina Lavopa; Anna Maria Caringella
Journal:  J Ovarian Res       Date:  2010-11-09       Impact factor: 4.234

10.  Serum soluble glycoprotein 130 concentration is inversely related to insulin sensitivity in women with polycystic ovary syndrome.

Authors:  Agnieszka Nikolajuk; Irina Kowalska; Monika Karczewska-Kupczewska; Agnieszka Adamska; Elzbieta Otziomek; Slawomir Wolczynski; Ida Kinalska; Maria Gorska; Marek Straczkowski
Journal:  Diabetes       Date:  2010-01-26       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.